Nuclear receptor E75/NR1D2 promotes tumor malignant transformation by integrating Hippo and Notch pathways.

Saved in:
Bibliographic Details
Title: Nuclear receptor E75/NR1D2 promotes tumor malignant transformation by integrating Hippo and Notch pathways.
Authors: Wang X; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China. wangxianping@westlake.edu.cn.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China. wangxianping@westlake.edu.cn., Guo Y; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China., Lin P; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China., Yu M; Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China., Song S; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China., Xu W; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China., Kong D; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China., Wang Y; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China.; Department of Diabetes & Cancer Metabolism, Beckman Research Institute of City of Hope National Medical Center, Duarte, CA, 91010, USA., Zhang Y; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China., Lu F; State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, 518055, China., Xie Q; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China. xieqi@westlake.edu.cn.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China. xieqi@westlake.edu.cn., Ma X; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China. maxianjue@westlake.edu.cn.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China. maxianjue@westlake.edu.cn.
Source: The EMBO journal [EMBO J] 2024 Dec; Vol. 43 (24), pp. 6336-6363. Date of Electronic Publication: 2024 Nov 08.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39516282
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nuclear receptor E75/NR1D2 promotes tumor malignant transformation by integrating Hippo and Notch pathways.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China. wangxianping@westlake.edu.cn.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China. wangxianping@westlake.edu.cn.<br /><searchLink fieldCode="AU" term="%22Guo+Y%22">Guo Y</searchLink>; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Lin+P%22">Lin P</searchLink>; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Yu+M%22">Yu M</searchLink>; Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.<br /><searchLink fieldCode="AU" term="%22Song+S%22">Song S</searchLink>; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Xu+W%22">Xu W</searchLink>; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Kong+D%22">Kong D</searchLink>; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China.; Department of Diabetes & Cancer Metabolism, Beckman Research Institute of City of Hope National Medical Center, Duarte, CA, 91010, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Lu+F%22">Lu F</searchLink>; State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.<br /><searchLink fieldCode="AU" term="%22Xie+Q%22">Xie Q</searchLink>; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China. xieqi@westlake.edu.cn.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China. xieqi@westlake.edu.cn.<br /><searchLink fieldCode="AU" term="%22Ma+X%22">Ma X</searchLink>; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, 310024, Zhejiang, China. maxianjue@westlake.edu.cn.; School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China. maxianjue@westlake.edu.cn.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228208664%22">The EMBO journal</searchLink> [EMBO J] 2024 Dec; Vol. 43 (24), pp. 6336-6363. <i>Date of Electronic Publication: </i>2024 Nov 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8208664 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2075 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202614189%22">02614189 </searchLink><i>NLM ISO Abbreviation: </i>EMBO J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39516282
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s44318-024-00290-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6336
    Titles:
      – TitleFull: Nuclear receptor E75/NR1D2 promotes tumor malignant transformation by integrating Hippo and Notch pathways.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Guo Y
      – PersonEntity:
          Name:
            NameFull: Lin P
      – PersonEntity:
          Name:
            NameFull: Yu M
      – PersonEntity:
          Name:
            NameFull: Song S
      – PersonEntity:
          Name:
            NameFull: Xu W
      – PersonEntity:
          Name:
            NameFull: Kong D
      – PersonEntity:
          Name:
            NameFull: Wang Y
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Lu F
      – PersonEntity:
          Name:
            NameFull: Xie Q
      – PersonEntity:
          Name:
            NameFull: Ma X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2024 Dec
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1460-2075
          Numbering:
            – Type: volume
              Value: 43
            – Type: issue
              Value: 24
          Titles:
            – TitleFull: The EMBO journal
              Type: main
ResultId 1